Ameloblastoma: current etiopathological concepts and management.
Effiom OA, Ogundana OM, Akinshipo AO, Akintoye SO.
Oral Dis. 2018 Apr;24(3):307-316. doi: 10.1111/odi.12646. Epub 2017 Mar 9.
Radical vs conservative treatment of intraosseous ameloblastoma: Systematic review and meta-analysis.
Hendra FN, Natsir Kalla DS, Van Cann EM, de Vet HCW, Helder MN, Forouzanfar T.
Oral Dis. 2019 Oct;25(7):1683-1696. doi: 10.1111/odi.13014. Epub 2019 Jan 1.
Ameloblastoma-Clinical, radiological, and therapeutic findings.
Kreppel M, Zöller J.
Oral Dis. 2018 Mar;24(1-2):63-66. doi: 10.1111/odi.12702.
Melanotic neuroectodermal tumor of infancy of the jaw bones: Update on the factors influencing survival and recurrence.
Pontes FSC, de Souza LL, Uchôa DCC, Joaquim AMC, do Nascimento LS, da Mata Rezende DDS, Pontes HAR.
Head Neck. 2018 Dec;40(12):2749-2756. doi: 10.1002/hed.25514. Epub 2018 Nov 2.
Osteosarcomas of jaw: experience of a single centre.
Argon A, Doğanavşargıl B, Ünal Yıldırım F, Sezak M, Midilli R, Öztop F.
J Plast Surg Hand Surg. 2015 Feb;49(1):13-8. doi: 10.3109/2000656X.2014.909364. Epub 2014 Apr 30.
Osteosarcoma of the jaw.
Delgado R, Maafs E, Alfeiran A, Mohar A, Barrera JL, Zinser J, Beltran A.
Head Neck. 1994 May-Jun;16(3):246-52. doi: 10.1002/hed.2880160307.
Ameloblastoma.
Mendenhall WM, Werning JW, Fernandes R, Malyapa RS, Mendenhall NP.
Am J Clin Oncol. 2007 Dec;30(6):645-8. doi: 10.1097/COC.0b013e3181573e59.
Osteosarcoma of the jaw bones.
Chindia ML.
Oral Oncol. 2001 Oct;37(7):545-7. doi: 10.1016/s1368-8375(00)00129-9.
Parathyroid carcinoma: molecular therapeutic targets.
Marini F, Giusti F, Palmini G, Aurilia C, Donati S, Brandi ML.
Endocrine. 2023 Sep;81(3):409-418. doi: 10.1007/s12020-023-03376-w. Epub 2023 May 9.
Nonodontogenic Tumors of the Jaws.
Dyalram D, Aslam-Pervez N, Lubek JE.
Oral Maxillofac Surg Clin North Am. 2016 Feb;28(1):59-65. doi: 10.1016/j.coms.2015.08.002.
